PBE.US Invesco Dynamic Biotechnology & Genome ETF

- USD
No recent price
Total assets
438M
Expense ratio
0.58%
Dividend yield
1.30%
1-year return
+31.78%
Holdings
31
Since
2005

Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.

What does PBE.US invest in?

  • Mostly US stocks (99.2%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (100.0%)
  • Top 3 holdings: 17.0% of the fund

Asset allocation

  • US stocks 99.2%
  • Cash 0.0%

Top holdings

All holdings, sectors and regions

Invesco Dynamic Biotechnology & Genome ETF performance

Sharpe ratio 1.25
This year
+23.56%
1 year
+31.78%
3 years
+23.03%
5 years
+7.05%

Volatility 16.0% over 1 year and 16.5% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

PBE.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About Invesco Dynamic Biotechnology & Genome ETF

Under normal circumstances, at least 80% of the value of its net assets, plus the amount of any borrowings for investment purposes, in securities of companies engaged in biotechnology- and genome-related industries, and in derivatives and other investments that have economic characteristics similar to securities of companies engaged in biotechnology- and genome-related industries (the "80% investment policy"). It is non-diversified.

Full fund profile